Federal March-In Rights Meet Clawbacks – The Future of 35 USC ss. 200-212 |

by Biotech Newsroom


This post could have been “The Revival of the March-In Rights of the Bayh-Dole Act.”

The passage of the Bayh-Dole Act in 1980 permitted universities to take title to inventions made with federal funding and grant licenses to commercial entities. These licenses were notably to “small business concerns” such as start-ups in the pharma and biotech ventures running on capital attracted by professors and their IP rights. Sections 200-212 covered the “who, how, what and were” requirements for universities to obtain title to…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC